Citations (11)
Keep up to date with the latest research on this topic with citation updates for this article.
Read on this site (1)
Jieke Yan, Yuzhen Wang, Xufeng Zhang, Shuangde Liu, Chuan Tian & Hongwei Wang. (2016) Targeted nanomedicine for prostate cancer therapy: docetaxel and curcumin co-encapsulated lipid–polymer hybrid nanoparticles for the enhanced anti-tumor activity in vitro and in vivo. Drug Delivery 23:5, pages 1757-1762.
Read now
Read now
Articles from other publishers (10)
Jieke Yan, Yuzhen Wang, Yuxiu Jia, Shuangde Liu, Chuan Tian, Wengu Pan, Xiaoli Liu & Hongwei Wang. (2017) Co-delivery of docetaxel and curcumin prodrug via dual-targeted nanoparticles with synergistic antitumor activity against prostate cancer. Biomedicine & Pharmacotherapy 88, pages 374-383.
Crossref
Crossref
Chenhong Wang, Yongtao Ma, Siliang Feng, Keliang Liu & Ning Zhou. (2015)
Gonadotropin-releasing hormone receptor-targeted paclitaxel-degarelix conjugate: synthesis and
in vitro
evaluation
. Journal of Peptide Science 21:7, pages 569-576.
Crossref
Crossref
Kyung Seok HanSung Joon Hong. (2015) Exponential Rise in Prostate-Specific Antigen (PSA) during Anti-Androgen Withdrawal Predicts PSA Flare after Docetaxel Chemotherapy in Patients with Castration-Resistant Prostate Cancer. Yonsei Medical Journal 56:2, pages 368.
Crossref
Crossref
Abhijit Saha, Saswat Mohapatra, Prashant Kurkute, Batakrishna Jana, Jayita Sarkar, Prasenjit Mondal & Surajit Ghosh. (2015) Targeted delivery of a novel peptide–docetaxel conjugate to MCF-7 cells through neuropilin-1 receptor: reduced toxicity and enhanced efficacy of docetaxel. RSC Advances 5:112, pages 92596-92601.
Crossref
Crossref
Kyung Seok Han & Sung Joon Hong. (2014) Serum alkaline phosphatase differentiates prostate-specific antigen flare from early disease progression after docetaxel chemotherapy in castration-resistant prostate cancer with bone metastasis. Journal of Cancer Research and Clinical Oncology 140:10, pages 1769-1776.
Crossref
Crossref
Yun Luo, You Ling, Wusheng Guo, Jun Pang, Weipeng Liu, Youqiang Fang, Xinqiao Wen, Kun Wei & Xin Gao. (2010) Docetaxel loaded oleic acid-coated hydroxyapatite nanoparticles enhance the docetaxel-induced apoptosis through activation of caspase-2 in androgen independent prostate cancer cells. Journal of Controlled Release 147:2, pages 278-288.
Crossref
Crossref
Yang-Min Ning, Ramzi N. Dagher & Richard Pazdur. 2010. Drug Management of Prostate Cancer. Drug Management of Prostate Cancer
399
405
.
Sneha Sundaram, Ruchit Trivedi, Chandrasekar Durairaj, Rajagopal Ramesh, Balamurali K. Ambati & Uday B. Kompella. (2009) Targeted Drug and Gene Delivery Systems for Lung Cancer Therapy. Clinical Cancer Research 15:23, pages 7299-7308.
Crossref
Crossref
. (2009) Current World Literature. Current Opinion in Oncology 21:4, pages 386-392.
Crossref
Crossref
Sneha Sundaram, Chandrasekar Durairaj, Rajendra Kadam & Uday B. Kompella. (2009) Luteinizing hormone-releasing hormone receptor–targeted deslorelin-docetaxel conjugate enhances efficacy of docetaxel in prostate cancer therapy. Molecular Cancer Therapeutics 8:6, pages 1655-1665.
Crossref
Crossref